Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Tianjin Behigh Pharmaceutical, a China-based subsidiary of Niusule Biotech, said that it has received 95.4 points (out of 100) on its GMP (Good Manufacturing Practices) re-inspection from the Ministry of Agriculture of the People's Republic of China which was conducted on May 29-30, 2010, in accordance with the Ministry's required five-year re-evaluation.
Subscribe to our email newsletter
The various aspects evaluated during the inspection include line production, laboratory safety, production control, inventory logistics on over 100 products, upkeep of the physical property, and proper management and all areas exceeded the Ministry’s standards.
Amy Hu, president and CEO of Niusule, said: “Niusule is proud of our management and operations. Our dedication to the health, safety, and welfare of our facilities, employees, and customers is ingrained in our corporate culture. Having our internal standards measured and recognised by the Chinese Ministry of Agriculture validates our efforts.
“We will continue on this path going forward, particularly as we look to expand our facilities at a future date. On the sales side, the GMP’s positive inspection provides credibility as we market our products to new clients as well as further expand our sales across China.”